|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02327 MEILLEUREHEALTH
Nominal 
0.305 -0.005 (-1.613%) | 2022/12 - Final HKD(K$) | %Chg (Compare to Final) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | 2018/12 HKD(K$) | |
| Turnover | 119,894 | -52.617% | 253,031 | 265,135 | 234,779 | 230,542 |
| Cost of Sales | (53,133) | -65.068% | (152,102) | (153,884) | (162,947) | (140,320) |
| Gross Profit | 66,761 | -33.854% | 100,929 | 111,251 | 71,832 | 90,222 |
| 2022/12 - Final HKD(K$) | %Chg (Compare to Final) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | 2018/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | 13,581 | -10.592% | 15,190 | (16,869) | 21,990 | 56,227 | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | (33,017) | (17,534) | |
| Profit / (Loss) on Disposal | 9,435 | -36.439% | 14,844 | 45,785 | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (14,774) | 33.484% | (11,068) | (4,201) | (21,763) | 8,080 | |
| Profit / (Loss) before Taxation | 25,385 | -70.381% | 85,704 | 103,587 | (5,344) | 106,583 | |
| Taxation | (7,605) | -69.879% | (25,248) | (18,521) | (17,666) | (25,059) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 42 | -- | (133) | (1,627) | 2,836 | (987) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 17,822 | -70.456% | 60,323 | 83,439 | (20,174) | 80,537 | |
| 2022/12 - Final HKD(K$) | %Chg (Compare to Final) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | 2018/12 HKD(K$) | |
| Net Finance Costs / (Income) | (15,460) | 280.413% | (4,064) | 5,445 | 8,141 | 12,340 |
| Depreciation & Amortisation | 3,852 | 7.718% | 3,576 | 7,909 | 6,192 | 1,163 |
| Directors' Emoluments | 2,614 | -33.621% | 3,938 | 4,566 | 2,512 | 1,820 |
| 2022/12 - Final | %Chg (Compare to Final) | 2021/12 | 2020/12 | 2019/12 | 2018/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2022/12 - Final | %Chg (Compare to Final) | 2021/12 | 2020/12 | 2019/12 | 2018/12 | |
| EPS (cts) | 0.430 | -69.718% | 1.420 | 1.950 | -0.480 | 2.150 |
| DPS (cts) | 1.600 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | 372.093% | -- | -- | -- | -- | -- |
| Cash flow per share ($) | 0.011 | -- | (0.020) | 0.017 | 0.006 | 0.005 |
| NBV per share ($) | 0.323 | -- | 0.339 | 0.328 | 0.295 | 0.209 |
| Remarks: | Real time quote last updated: 13/05/2025 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD 17,822,000 |
| %Change | -70.456% |
| EPS / (LPS) | HKD 0.004 |
| NBV Per Share ($) | HKD 0.323 |